English Українська
  • Main
  • Useful links
  • Information for Contributors
  • About
  • Editorial board

  • Article
    Pavlovska М. О.

    CLINICAL FEATHERS OF LEIOMYOMA ON THE BACKGROUND OF METABOLIC SYNDROME


    About the author: Pavlovska М. О.
    Heading CLINICAL MEDICINE
    Type of article Scentific article
    Annotation The research involved 30 patients with leiomyoma associated with metabolic syndrome and 34 control group patients without leiomyoma. Found that in women with uterine leiomyoma associated with metabolic syndrome in the pathogenesis of the disease and age at first period, menopause occurs earlier. Obstetric and gynecological history showed fewer pregnancies and births of some physiological increase in abnormal births, three times more frequently diagnosed infertility. Violation of ovarian-menstrual bleeding occur ovulatory (in 6.7% of cases), excessive bleeding in the perimenopausal period (in 10.0% of cases), the development of amenorrhea and oligomenorrhea. Patients in this group often used hormonal oral contraceptives. Localization of myoma units in the second interstitial age period in 73.1% of cases. Leiomyoma belong to the type I, II and III type equally. Neuro-endocrine status characterized by a probable increase in estradiol levels, decrease – slight decrease of progesterone and DHEA-S. The content of gonadotropin hormones differs little from that of healthy women.
    Tags uterine leiomyoma, metabolic syndrome, hormonal status
    Bibliography
    • Voropotvelyan P. N. Mioma matki u zhenschin reproduktivnogo vozrasta / P. N. Voropotvelyan, A. A. Bondarenko. N. P. Voropotvelyan // Zdorove zhenschinyi. – 2015. – No.10. - S. 153-156.
    • Ginekologicheskaya zabolevaemost i reproduktivnyie vozmozhnosti zhenschin s ozhireniem / B. B. Pinhasov, G. A. Skosyireva, Yu. P. Shorin [i dr.] // Vestnik NGU. Seriya:Biologiya,klinicheskaya meditsina.– 2010. – Tom 8, vyip. 2. – S. 62-67.
    • Zaporozhan V. M. Akusherstvo i ginekologiya. Pidruchnik: u 2-h tomah. T.2. / V. M. Zaporozhan, M. R. Tsegelskiy, N. M. Rozhkovska // – Odesa., - 2005. – 420 s.
    • Zaporozhan V. M. Faktori riziku rozvitku miomi matki u zhinok reproduktivnogo viku / V. M. Zaporozhan, S. M. Neporada // Odeskiy medichniy zhurnal. – 2014. – No.2 (162). – S. 37-40.
    • Kondratovich L. M. Sovremennyiy vzglyad na etiologiyu, patogenez i sposobyi lecheniya miomyi matki / L. M. Kondratovich // Rossiyskiy meditsinskiy zhurnal. – 2014. – No.5. – S. 36-40.
    • Masyakina A. V. Diagnostika i lechenie dobrokachestvennyih giperplasticheskih zabolevaniy matki u zhenschin s endokrinno-obmennyimi narusheniyami / Masyakina A.V., Kudrina E.A. // Arhiv akuscherstva i ginekologii im. V.F. Snegireva. – 2015. – No.3. – S. 20-24.  
    • Chayka K. V. Istoriya voprosa i sovremennyie predstavleniya ob etiologii, pato- i morfogeneze leyomiomyi matki / K. V. Chayka, T. N. Demina, N. A. Firsova // Mediko-sotsialni problemi sim'yi. – 2014. – Tom 19, No.3. – S. 58-67.
    • Chernuha G. E. Ozhirenie kak faktor riska narusheniy reproduktivnoy sistemyi u zhenschin / E. E. Chernuha // Consilium Medicum. – 2007. – No.6. – C. 115-118. 
    • Chubey G. V. Aktualni pitannya etiologiyi ta patogenezu leyomiomi matki u zhinok reproduktivnogo viku / G. V. Chubey // Zdorove zhenschinyi. – 2013. – No.10. – S. 10-15.
    • Shtoh E. A. Mioma matki. Sovremennoe predstavlenie o patogeneze i faktorah riska / E. A. Shtoh, V. B. Tshay // Sibirskoe meditsinskoe obozrenie. – 2015. – 1. - S. 22-27.
    • Yavorskiy P. V. Ozhirinnya ta stan statevih steroyidiv u zhinok z leyomiomoyu matki / P. V. Yavorskiy // // Ukrayina. Zdorovya natsiyi. – 2012. – No.1 (17). – S. 98-101.
    • Yavorskiy P. V. Znachennya koefitsienta poednannya dlya kilkisnoyi harakteristiki vplivu etiologichnih chinnikiv leyomiomi matki / P. V. Yavorskiy // Ukrayina. Zdorovya natsiyi. – 2012. – No.3 (23). – S.294-299.
    • Yarotskiy M. E. Novi pidhodi do diagnostiki dobroyakisnih zahvoryuvan matki u zhinok reproduktivnogo viku z metabolichnim sindromom / M. E. Yarotskiy, L. V. Demyanenko // Klinichna endokrinologiya ta endokrinna hirurgiya. – 2015. – No.2. – S. 51-57. 
    • Cook J. D. Treatment strategies for uterine leiomyoma: the role of hormonal modulation / J.D. Cook // Reprod. Med. – 2004. – Vol.22 (2). – P. 53-62.
    • Zhao Y. The expression of estrogen receptor isoforms alpha, beta and insulin-like growth factor-1 in uterine leiomyoma / Y. Zhao, W. Zhang, S. Wang // Gynecol. Endocrinol. – 2008. –Vol.24, №10. – P. 549-554.
    Publication of the article «World of Medicine and Biology» №1(59), 2017 year, 068-072 pages, index UDK 618.14-006.363.03:[616.12-008.331.1+616-056.52